title: Long-term follow-up in superficial transitional cell carcinoma of the bladder: prognostic factors for time to first recurrence, recurrence rate, and survival. Final results of a randomized trial comparing doxorubicin hydrochloride, ethoglucid, and transurethral resection alone. EORTC Genitourinary Tract Cancer Cooperative Group.
authors.affiliation: Dept. of Urology, University of Amsterdam, NL.
authors.forename: K
authors.initials: K
authors.lastname: Kurth
authors.forename: F H
authors.initials: FH
authors.lastname: Schroeder
authors.forename: F
authors.initials: F
authors.lastname: Debruyne
authors.forename: T
authors.initials: T
authors.lastname: Senge
authors.forename: M
authors.initials: M
authors.lastname: Pavone-Macaluso
authors.forename: M
authors.initials: M
authors.lastname: de Pauw
authors.forename: F
authors.initials: F
authors.lastname: ten Kate
authors.forename: R
authors.initials: R
authors.lastname: Sylvester
mesh_terms: D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000601:surgery*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000627:therapeutic use*; D004987:Ethers / Q000627:therapeutic use*; D005009:Ethoglucid / Q000627:therapeutic use*; D005060:Europe; D005500:Follow-Up Studies; D006801:Humans; D015337:Multicenter Studies as Topic; D011379:Prognosis; D011897:Random Allocation; D001743:Urinary Bladder / Q000601:surgery*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000601:surgery*
chemical_list: D004987:Ethers; D005009:Ethoglucid; D004317:Doxorubicin